Palantir Technologies has recovered the $180 level it couldn't hold last week, closing Tuesday at $179.92 after a 4.2% gain over five sessions — but the options market is flashing mild caution, and the peer group picture has shifted enough to make the rebound worth interrogating.
The most telling signal this week is in options positioning. The put/call ratio has ticked above its recent average, running at 1.06 against a 20-day mean of 1.01 — not an alarming spread, but the direction matters. Palantir's PCR spent the first three weeks of August well below 1.0, then crossed above it around August 21 and has stayed there. The 52-week low on the PCR was 0.61, the high 1.16 — so the current reading is in the upper third of the range without hitting extremes. Short interest, meanwhile, has eased. It dropped another 7.4% over the week to roughly 2.9% of free float — down from approximately 3.2% just a fortnight ago, and well below the mid-July peak near 3.5%. The borrow market remains completely relaxed: cost to borrow is under 0.28% and availability is at the ceiling of the reporting range, meaning there is essentially no constraint on new short supply. The lending data tells a story of declining bearish conviction, even as options traders apply modest downside protection.
The Street backdrop is constructive but dated. Following the August 4 earnings print — when the stock surged 32% in a single session — a cluster of analysts raised targets. Citigroup went to $245, Piper Sandler held at $230, Mizuho lifted to $215, and UBS moved to $220, all maintaining positive ratings. Deutsche Bank upgraded from Hold to Buy at $200. Only Cantor Fitzgerald stayed Neutral, raising its target to $156. That post-earnings wave of upgrades is now almost four weeks old, and the consensus mean target of $185 sits only about 3% above Tuesday's close — implying the Street already largely priced in the move. The valuation picture reinforces the stretch: the trailing P/E is near 90x and price-to-book is above 27x, both up meaningfully over the past month. EPS momentum scores rank in the 90th percentile on a 30-day basis, reflecting the strong beat, but the forward earnings growth score sits at just the 15th percentile — a reminder that much of the near-term good news is already absorbed.
The peer group has become a more interesting frame for Palantir this week than short interest. ZETA added 13.2% over the five sessions and NOW gained 12.5%, both outpacing Palantir's 4.2% recovery by a wide margin. PATH added 8.9%. On the other end, RBRK shed 4.6% and SOUN lost 2.8%. Palantir sits in the middle of the peer range — no longer the laggard it was in last week's note, but not leading the group either. The previous note flagged that Palantir's inability to hold $180 when peers were trending higher raised a ceiling question; the stock has now reclaimed that level on a closing basis, though Tuesday's 3.5% pullback on the day suggests the level is contested.
The ORTEX short score is drifting lower, from around 32.6 a week ago to 31.7 now — consistent with easing short interest and abundant borrow — and ranks in roughly the 64th percentile on the short score factor. Institutional flow is unremarkable: BlackRock and Vanguard both added small positions in their most recent reported periods, and State Street added nearly 2.9 million shares. None of these moves are directional signals — they track index flows — but they confirm no institutional seller of scale has emerged since the earnings pop.
The next earnings date is November 2. Between now and then, the debate is whether $179-$180 represents a genuine consolidation base after the August surge, or whether the convergence of a near-consensus price target, a 90x P/E, and only modest peer outperformance signals that the post-earnings re-rating has run its course — and the burden of proof now rests entirely on the next revenue print.
See the live data behind this article on ORTEX.
Open PLTR on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
